1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. EDITAS MEDICINE INC
Editas Medicine Inc
XNAS: EDIT

Editas Medicine Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform ba...

Read More
2.44 -0.10 (-3.94%)
46.26% Fall from 52W High
1.2M
XNAS Volume

XNAS 13 Mar, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Editas Medicine Inc is on 19 Mar 2026 for the purpose of Editas Medicine Inc Annual Report for 2025 See details
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
11.7 / 100
Momentum Score
Technically Neutral
52.6 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
6
1Yr Price target upside is 125%
9 analysts

13

S

10

W

0

O

2

T

SWOT Analysis

Editas Medicine Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..